Insiders · Profile

GARCIA PETER S

CHIEF FINANCIAL OFFICER at ALX ONCOLOGY · Chief Financial Officer at Lineage Cell Therapeutics. Filing since 29 Nov 2011. CIK 0001188956

ALXO ALX ONCOLOGY HOLDINGS INC CHIEF FINANCIAL OFFICER · 10 trades LCTX Lineage Cell Therapeutics, Inc. Chief Financial Officer · 2 trades

Company

Date

Role

Action

Shares

Amount

Of holding

ALXO ALX ONCOLOGY HOLDINGS INC

13 Jun 2024

CHIEF FINANCIAL OFFICER

Bought

12,000

$102.34K

10.9%

ALXO ALX ONCOLOGY HOLDINGS INC

29 Dec 2023

Chief Financial Officer

Sold at will

1,893

$28.47K

2.2%

ALXO ALX ONCOLOGY HOLDINGS INC

30 Jun 2023

Chief Financial Officer

Sold at will

887

$6.51K

1.6%

ALXO ALX ONCOLOGY HOLDINGS INC

29 Dec 2022

Chief Financial Officer

Sold, plan not stated

893

$9.89K

1.6%

ALXO ALX ONCOLOGY HOLDINGS INC

18 Oct 2021

Chief Financial Officer

Sold, plan not stated

7,229

$400.79K

43.7%

ALXO ALX ONCOLOGY HOLDINGS INC

17 Sep 2021

Chief Financial Officer

Sold, plan not stated

11,345

$895.81K

54.9%

ALXO ALX ONCOLOGY HOLDINGS INC

16 Sep 2021

Chief Financial Officer

Sold, plan not stated

1,426

$114.69K

13.3%

ALXO ALX ONCOLOGY HOLDINGS INC

23 Aug 2021

Chief Financial Officer

Sold, plan not stated

60,000

$4.45M

86.5%

ALXO ALX ONCOLOGY HOLDINGS INC

17 Aug 2021

Chief Financial Officer

Sold, plan not stated

10,000

$662.30K

51.7%

ALXO ALX ONCOLOGY HOLDINGS INC

21 Jul 2020

Chief Financial Officer

Bought

3,000

$57.00K

opened

LCTX Lineage Cell Therapeutics, Inc.

19 Mar 2012

Chief Financial Officer

Bought

5,000

$23.38K

250%

LCTX Lineage Cell Therapeutics, Inc.

29 Nov 2011

Chief Financial Officer

Bought

2,000

$8.34K

opened

12 decisions on file.